What are people saying about HCS products?
"I would go back to this time and time again. I feel it's reassuring and it gives you good steps to practice."
—diabetes adherence program user
The bottom line is product value – profile divided by cost. This has been true for payers and tight budgets is increasing enforcement vigilance. Barriers to treatment and rising co-pays make value more important every day to patients and prescribers. Finally, REMS and other increased post-marketing requirements mean that regulators can manage certain safety issues if the value equation warrants the bother.